cl 387785 has been researched along with Acinar Carcinoma in 1 studies
CL 387785: structure in first source
N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}but-2-ynamide : A member of the class of quinazolines that is 4,6-diaminoquinazoine in which the one of the hydrogens attached to the amino group at position 4 has been replaced by a m-bromophenyl group while one of the hydrogens attached to the amino group at position 6 has been replaced by a but-2-ynoyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, JH | 1 |
| Rho, JK | 1 |
| Xu, X | 1 |
| Lee, JS | 1 |
| Yoon, HI | 1 |
| Lee, CT | 1 |
| Choi, YJ | 1 |
| Kim, HR | 1 |
| Kim, CH | 1 |
| Lee, JC | 1 |
1 other study available for cl 387785 and Acinar Carcinoma
| Article | Year |
|---|---|
Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplati | 2011 |